循环微RNA用于识别人类心力衰竭。 - Suppr | 超能文献

Circulating microRNAs to identify human heart failure.

作者信息

Seto Anita G, van Rooij Eva

出版信息

Eur J Heart Fail. 2012 Feb;14(2):118-9. doi: 10.1093/eurjhf/hfr179.

DOI:10.1093/eurjhf/hfr179

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Circulating microRNAs to identify human heart failure.循环微RNA用于识别人类心力衰竭。

Eur J Heart Fail. 2012 Feb;14(2):118-9. doi: 10.1093/eurjhf/hfr179.

2

Serum levels of microRNAs in patients with heart failure.心力衰竭患者血清 microRNAs 水平。

Eur J Heart Fail. 2012 Feb;14(2):147-54. doi: 10.1093/eurjhf/hfr155. Epub 2011 Nov 25.

3

Relation of reduced expression of MiR-150 in platelets to atrial fibrillation in patients with chronic systolic heart failure.血小板中 miR-150 表达降低与慢性收缩性心力衰竭患者心房颤动的关系。

Am J Cardiol. 2014 Mar 15;113(6):976-81. doi: 10.1016/j.amjcard.2013.11.060. Epub 2013 Dec 25.

4

Use of biomarkers to establish potential role and function of circulating microRNAs in acute heart failure.利用生物标志物确定循环微RNA在急性心力衰竭中的潜在作用和功能。

Int J Cardiol. 2016 Dec 1;224:231-239. doi: 10.1016/j.ijcard.2016.09.010. Epub 2016 Sep 11.

5

The relationship between circulating microRNAs and left ventricular mass in symptomatic heart failure patients with systolic dysfunction.有症状的收缩功能障碍性心力衰竭患者循环微RNA与左心室质量之间的关系。

Kardiol Pol. 2015;73(9):740-6. doi: 10.5603/KP.a2015.0082. Epub 2015 May 19.

6

Polymorphisms of matrix metalloproteinases in systolic heart failure: role on disease susceptibility, phenotypic characteristics, and prognosis.基质金属蛋白酶多态性与收缩性心力衰竭：在疾病易感性、表型特征和预后中的作用。

J Card Fail. 2011 Feb;17(2):115-21. doi: 10.1016/j.cardfail.2010.09.017. Epub 2010 Dec 3.

7

Endothelial nitric oxide synthase polymorphism and prognosis in systolic heart failure patients.收缩性心力衰竭患者的内皮型一氧化氮合酶基因多态性与预后

Nitric Oxide. 2015 May 1;47:91-6. doi: 10.1016/j.niox.2015.04.004. Epub 2015 Apr 23.

8

MicroRNAs as circulating biomarkers for heart failure: questions about MiR-423-5p.微小RNA作为心力衰竭的循环生物标志物：关于MiR-423-5p的问题

Circ Res. 2010 May 14;106(9):e8; author reply e9. doi: 10.1161/CIRCRESAHA.110.220616.

9

The impact of coronary artery disease risk loci on ischemic heart failure severity and prognosis: association analysis in the COntrolled ROsuvastatin multiNAtional trial in heart failure (CORONA).冠状动脉疾病风险基因座对缺血性心力衰竭严重程度和预后的影响：心力衰竭辛伐他汀多国对照试验（CORONA）中的关联分析

BMC Med Genet. 2014 Dec 21;15:140. doi: 10.1186/s12881-014-0140-3.

10

Polymorphisms of MMP-2 gene are associated with systolic heart failure prognosis.基质金属蛋白酶-2基因多态性与收缩性心力衰竭的预后相关。

Clin Chim Acta. 2009 Jun 27;404(2):119-23. doi: 10.1016/j.cca.2009.03.030. Epub 2009 Mar 28.

引用本文的文献

1

miR-454-3p and miR-194-5p targeting cardiac sarcolemma ion exchange transcripts are potential noninvasive diagnostic biomarkers for childhood dilated cardiomyopathy in Egyptian patients.靶向心肌肌膜离子交换转录本的miR-454-3p和miR-194-5p是埃及儿童扩张型心肌病潜在的无创诊断生物标志物。

Egypt Heart J. 2022 Sep 8;74(1):65. doi: 10.1186/s43044-022-00300-x.

2

Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction.循环心脏特异性 microRNAs 与心肌梗死后的长期预后相关。

BMC Cardiovasc Disord. 2013 Feb 28;13:12. doi: 10.1186/1471-2261-13-12.